Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response in Melanoma or NSCLC Participants

Conditions:   Melanoma;   Non-Small Cell Lung Cancer Intervention:   Drug: Single Arm Sponsors:   Cytosite Biopharma Inc.;   Massachusetts General Hospital;   University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials